Skip to main content
. 2024 Jun 28;39(2):122–131. doi: 10.4274/MMJ.galenos.2024.53822

Table 1. Characteristics of the included studies about country, type of disease, form of supplement, age, and duration consumption probiotic.

No

Author (Reference)

Country

Type of disease

Form of supplement

Age (y)

Duration (weeks)

1

Han et al.11, 2012

Korea

Atopic dermatitis

Yogurts

1-13

12

2

Harima-Mizusawa et al.14, 2016

Japan

Allergic rhinitis

Juice

16-65

8

3

Ishida et al.15, 2005

Japan

Allergic rhinitis

Milk

34-36

8

4

Kawase et al.17, 2009

Japan

Japanese cedar pollinosis

Milk

20-57

10

5

Hummelen et al.19, 2011

Canada

HIV

Yogurts

>18

4

6

Parra et al.20, 2004

Spain

Healthy person

Yoghurt

51-58

8

7

Bunout et al.21, 2004

Switzerland

Healthy eldery

Powder

>70

16

8

Miyazawa et al.22, 2015

Japan

Healthy eldery

Tablet

50-70

4

9

Mangalat et al.23, 2012

America

Healthy adults

Tablet

19-60

8

10

Drago et al.13, 2011

Italy

Atopic dermatitis

Powder

10-46

16

11

Tamura et al.27, 2007

Japan

Allergic rhinitis

Milk

x=39

8

12

Hasegawa et al.18, 2009

Japan

Japanese cedar polinosis

Milk

x=35

8

13

Ivory et al.16, 2008

UK

Allergic rhinitis

Yogurt

18-45

2

14

Hirose et al.24, 2006

Japan

Healthy subjects

Capsule

40-64

12

15

Seifert et al.25 2011

Germany

Healthy individuals

Milk

18-60

4

16

Meyer et al.28 2007

Austria

Healthy young women

Yogurt

22-29

2

17

Costabile et al.29, 2017

UK

Hypercholesterolaemic

Capsular

30-65

12

18

Ahn et al.12, 2020

Korea

Atopic Dermatitis

Tablet

2-13

12

19

Baroja et al.<sub>26</sub>, 2007

Canada

Inflammatory bowel disease

Yogurt

26-63

4

20

Ouwehand et al.30, 2008

Finland

Healthy elderly

Powder

>65

2

x= mean of age. HIV: Human immunodeficiency virus